相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer
Xingya Wang et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level
Thea Veitonmaki et al.
EUROPEAN JOURNAL OF CANCER (2013)
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
Tuomas P. Kilpelainen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Malignancy as a comorbidity in rheumatic diseases
Carl Turesson et al.
RHEUMATOLOGY (2013)
Prostate cancer and inflammation: the evidence
Karen S. Sfanos et al.
HISTOPATHOLOGY (2012)
Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer
Ning Shao et al.
MOLECULAR BIOLOGY REPORTS (2012)
Aspirin and urologic cancer risk: an update
Cristina Bosetti et al.
NATURE REVIEWS UROLOGY (2012)
Nonsteroidal Antiinflammatory Drugs and Bladder Cancer: A Pooled Analysis
Sarah E. Daugherty et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer
Eunyoung Cho et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies
Y. Vinogradova et al.
BRITISH JOURNAL OF CANCER (2011)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Nonsteroidal Anti-inflammatory Drug and Acetaminophen Use and Risk of Adult Myeloid Leukemia
Julie A. Ross et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
SPINK1: A New Therapeutic Target in Cancer?
Ulf-Hakan Stenman
CLINICAL CHEMISTRY (2011)
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2011)
Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study)
Ali S. Murad et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Long-Term Use of Acetaminophen, Aspirin, and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Hematologic Malignancies: Results From the Prospective Vitamins and Lifestyle (VITAL) Study
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67
Elin Richardsen et al.
CANCER EPIDEMIOLOGY (2010)
Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
Theodore M. Brasky et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
Wenjing Tian et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis
Salaheddin M. Mahmud et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
E. David Crawford
UROLOGY (2009)
Risk factors for prostate cancer
Amit R. Patel et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A. Tomlins et al.
CANCER CELL (2008)
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee
Werner Hacke et al.
CEREBROVASCULAR DISEASES (2008)
The role of inflammation and infection in the pathogenesis of prostate carcinoma
Florian M. E. Wagenlehner et al.
BJU INTERNATIONAL (2007)
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Alaa Rostom et al.
ANNALS OF INTERNAL MEDICINE (2007)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo et al.
NATURE REVIEWS CANCER (2007)
The influence of chronic inflammation in prostatic carcinogenesis: A 5-year followup study
Gregory T. MacLennan et al.
JOURNAL OF UROLOGY (2006)
Risk of cancer in a large cohort of nonaspirin NSAID users:: a population-based study
HT Sorensen et al.
BRITISH JOURNAL OF CANCER (2003)
Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
DA Corley et al.
GASTROENTEROLOGY (2003)
Large-scale randomized prostate cancer screening trials:: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial
HJ de Koning et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Breast cancer and NSAID use: a meta-analysis
SA Khuder et al.
BRITISH JOURNAL OF CANCER (2001)
Interleukin-6 and prostate cancer progression
PC Smith et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database
MJS Langman et al.
BRITISH MEDICAL JOURNAL (2000)
Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors
SK Kulkarni et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2000)
分享论文
